Diagnosis and treatment of well differentiated thyroid cancer analysis and National Comprehensive Cancer Network guideline practice
Gong, S.; Zhang, Q.; Yu, Z.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(10): 878-880
2014
ISSN/ISBN: 1673-0860 PMID: 25573015 Document Number: 678957
Document emailed within 1 workday
Related Documents
1999: Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network Oncology 13(5a): 41-66Carlson, R.W.; Goldstein, L.J.; Gradishar, W.J.; Lichter, A.S.; McCormick, B.; Moe, R.E.; Theriault, R.L. 1996: NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network Oncology 10(11 Suppl): 47-75
1998: NCCN practice guidelines for the myelodysplastic syndromes. National Comprehensive Cancer Network Oncology 12(11a): 53-80
1999: NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network Oncology 13(5a): 113-147
Dietlein, M.; Dressler, J.; Eschner, W.; Leisner, B.; Reiners, C.; Schicha, H. 2003: Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 2) Nuklearmedizin. Nuclear Medicine 42(3): 123-125
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Drac-Kaniewska, J.; Kozłowicz-Gudzińska, I.; Tomaszewicz-Kubasik, H.; Kaniewski, M.; Godlewska, P.; Czetwertyńska, M.; Chaładaj-Kujawska, A. 2001: 99mTc Tetrofosmin in diagnosis of distant metastases from differentiated thyroid cancer Wiadomosci Lekarskie 54(Suppl 1): 357-362
Mori, Y.; Miyata, Y.; Takaya, K.; Satomi, S.; Sasaki, T.; Taguchi, Y.; Mori, S.; Sakita, Y. 1988: Assessment of the discriminant analysis concerning the prognostic factors in patients with differentiated thyroid cancer Nihon Geka Gakkai Zasshi 89(8): 1259-1266
Dănilă, R.; Popovici, R.; Andriescu, L.; Timofte, D.; Ungureanu, M.C.; Găluşcă, B.; Dragomir, C. 2007: The role of lymphadenectomy in the treatment of differentiated thyroid cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(1): 129-134
Martins, A.S.; Melo, G.M.; Valério, J.B.; Langner, E.; Lage, H.T.; Tincani, A.J. 2001: Treatment of locally aggressive well-differentiated thyroid cancer International Surgery 86(4): 213-219
Somboonporn, C.; Simthamnimit, P.; Puttharak, W.; Tumsatan, P.; Ngamjarus, C.; Roysri, K. 2010: Role of chest radiography in the diagnosis and follow-up of pulmonary metastasis in differentiated thyroid cancer Journal of the Medical Association of Thailand 93(Suppl 3): S52-S60
Zonderland, H.M.; Tuut, M.K.; den Heeten, G.J.; Asperen, C.J.; de Bock, G.H.; Rutqers, E.J.T.; Westenend, P.J.; Smit, G.M.H.; Benraadt, J. 2008: Revised practice guideline 'Screening and diagnosis of breast cancer' Nederlands Tijdschrift Voor Geneeskunde 152(43): 2336-2339
Lucchini, R.; Puxeddu, E.; Calzolari, F.; Burzelli, F.; Monacelli, M.; D'Ajello, F.; Macaluso, R.; Giammartino, C.; Ragusa, M.; De Feo, P.; Cavaliere, A.; Avenia, N. 2008: Recurrences of thyroid well differentiated cancer: ultrasonography-guided surgical treatment Minerva Chirurgica 63(4): 257-260
Ledent, C. 1996: Transgenic models of human thyroid pathologies: hyperfunctional adenoma, anaplastic cancer, differentiated cancer, hypothyroidism Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 151(2): 195-201
Niederle, B.; Roka, R.; Schemper, M.; Fritsch, A.; Weissel, M.; Ramach, W. 1986: Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results Surgery 100(6): 1088-1097
Palamarchuk, V.A. 2014: Complications after therapeutic dissection of the neck in the treatment of differentiated thyroid gland cancer Klinichna Khirurhiia 2014(1): 28-31
Hasse-Lazar, K.; Handkiewicz-Junak, D.; Roskosz, Józef.; Szpak-Ulczok, S.; Krajewska, J.; Jurecka-Lubieniecka, B.; Jarzab, B. 2006: Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences Endokrynologia Polska 57(4): 445-450
Kusić, Z.; Jukić, T.; Dabelić, N.; Franceschi, M. 2008: Croatian Thyroid Society guidelines for the management of patients with differentiated thyroid cancer Lijecnicki vjesnik 130(9-10): 213-227
Pietz, L.; Michałek, K.; Waśko, R.; Ruchała, M.; Sowiński, J. 2008: Influence of the endogene TSH stimulation of thyroid volume increase in the patients after total thyroidectomy due to differentiated thyroid cancer Endokrynologia Polska 59(2): 119-122
Ghinea, E.; Dumitriu, L.; Stefanovici, G.; Pop, A.; Damian, A.; Handoca, A.; Stanciu, R. 1988: Protein content and thyroid hormone release in vitro by differentiated thyroid cancer cells in the presence of estradiol, dehydroepiandrosterone, polypeptidic hormones and pesticides Endocrinologie 26(3): 165-171